Procter & GamblePGDON'T BUYOct 04, 2013Stock price when the opinion was issued
As of Jun 08, 2026. Market Open.
Owns neither. Of the two, he'd prefer JNJ. Hesitant to put them in the same basket. With spinoff of healthcare, it's now much more into pharmaceuticals (doing very well) and medical devices. Valuation is not that demanding. Executing well.
PG is a consumer products company. Consumer is in some difficulty, and jury's out as to whether we've seen the worst of that dip.
These consumer stocks are facing inflation. Revenue growth has been low, 3% the last quarter. Margins remain strong, though. Never been cheaper. Pays a 3% dividend. He isn't that bullish on the consumer, but PG is defensive. A good time to buy now, but don't expect a huge return, like 5-10% share appreciation + dividend.
Procter & Gamble (PG-N) or diversify with an ETF? In a lot of ways, mutual funds or ETFs are intended to give you diversification with smaller amounts of money and low costs. Until you build up a portfolio of some size, and can diversify in terms of numbers of positions, he would probably go with ETFs or mutual funds. Regarding Procter & Gamble, this kind of stock has befuddled him. In the last 6-8 months, these kinds of stocks are coming down in price because they were pushing up against their higher end on an evaluation basis.